World's Best Scientists 2026 revealed!
Pamela J. Goodwin

Pamela J. Goodwin

D-Index & Metrics

Medicine

D-Index
86
Citations
31678
World Ranking
13982
National Ranking
580

Overview

Pamela J. Goodwin is affiliated with the University of Toronto in Canada and has a significant body of work primarily in the fields of Medicine and Biochemistry, Genetics and Molecular Biology. Their research focuses notably on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Cancer Research, and Genetics.

They have contributed extensively to topics including Cancer Risks and Factors, Metabolism, Diabetes, and Cancer, Advanced Breast Cancer Therapies, Breast Cancer Treatment Studies, Nutritional Studies and Diet, Cancer, Lipids, and Metabolism, and Cancer-related Molecular Pathways.

Pamela J. Goodwin's recent papers include:

  • Effect of Metformin vs Placebo on Invasive Disease-Free Survival in Patients With Breast Cancer (2022, JAMA)
  • The LISA randomized trial of a weight loss intervention in postmenopausal breast cancer (2020, npj Breast Cancer)

Other frequent publication venues for their work are:

  • Journal of Clinical Oncology
  • JNCI Journal of the National Cancer Institute
  • npj Breast Cancer
  • Cancer Research
  • Clinical Cancer Research

They have collaborated frequently with several researchers, including:

  • Marguerite Ennis
  • Jennifer A. Ligibel
  • Dawn L. Hershman
  • Ana Elisa Lohmann
  • Bingshu E. Chen

Best Publications

  • Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013

    A Goldhirsch;E P Winer;A S Coates;R D Gelber

  • The Effect of Group Psychosocial Support on Survival in Metastatic Breast Cancer

    Pamela J. Goodwin;Molyn Leszcz;Marguerite Ennis;Jan Koopmans

  • De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017

    G. Curigliano;H. J. Burstein;E. P. Winer;M. Gnant

  • Fasting Insulin and Outcome in Early-Stage Breast Cancer: Results of a Prospective Cohort Study

    Pamela J. Goodwin;Marguerite Ennis;Kathleen I. Pritchard;Maureen E. Trudeau

  • Metformin and Cancer Risk in Diabetic Patients: A Systematic Review and Meta-analysis

    Andrea DeCensi;Matteo Puntoni;Pamela Goodwin;Massimiliano Cazzaniga

  • Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials

    Bernard Asselain;William Barlow;John Bartlett;Jonas Bergh

  • Risk of Menopause During the First Year After Breast Cancer Diagnosis

    Pamela J. Goodwin;Marguerite Ennis;Kathleen I. Pritchard;Maureen Trudeau

  • Double-blind randomised trial of very-low-dose warfarin for prevention of thromboembolism in stage IV breast cancer

    M. Levine;J. Hirsh;A. Arnold;M. Gent

  • Prognostic factors in osteosarcoma : a critical review

    A M Davis;R S Bell;P J Goodwin

  • Understanding the benefit of metformin use in cancer treatment

    Ryan J O Dowling;Pamela J Goodwin;Vuk Stambolic

  • Prevalence and Penetrance of BRCA1 and BRCA2 Gene Mutations in Unselected Ashkenazi Jewish Women With Breast Cancer

    Ellen Warner;William Foulkes;Pamela Goodwin;Wendy Meschino

  • Prognostic Effects of 25-Hydroxyvitamin D Levels in Early Breast Cancer

    Pamela J. Goodwin;Marguerite Ennis;Kathleen I. Pritchard;Jarley Koo

  • Metformin in cancer: translational challenges

    Ryan J O Dowling;Saroj Niraula;Vuk Stambolic;Pamela J Goodwin

  • Adjuvant Treatment and Onset of Menopause Predict Weight Gain After Breast Cancer Diagnosis

    Pamela J. Goodwin;Marguerite Ennis;Kathleen I. Pritchard;David McCready

  • Obesity and Breast Cancer Prognosis: Evidence, Challenges, and Opportunities

    Sao Jiralerspong;Pamela J Goodwin

  • Insulin and related factors in premenopausal breast cancer risk.

    M E Del Giudice;I G Fantus;I G Fantus;S Ezzat;G McKeown-Eyssen

  • Second Malignant Neoplasms: Assessment and Strategies for Risk Reduction

    Marie E. Wood;Victor Vogel;Andrea Ng;Lewis E Foxhall

  • Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-analysis of 37 298 women with early breast cancer in 26 randomised trials

    Richard Gray;Rosie Bradley;Jeremy Braybrooke;Zulian Liu

  • Health-Related Quality-of-Life Measurement in Randomized Clinical Trials in Breast Cancer—Taking Stock

    Pamela J Goodwin;Jeanne T Black;Louise J Bordeleau;Patricia A Ganz

  • Correction to: De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017 (Annals of Oncology (2017) 28(8) (1700–1712), (S0923753419321817), (10.1093/annonc/mdx308))

    G. Curigliano;H. J. Burstein;E. P. Winer;M. Gnant

Frequent Co-Authors

Kathleen I. Pritchard
Kathleen I. Pritchard University of Toronto
Vuk Stambolic
Vuk Stambolic University of Toronto
Irene L. Andrulis
Irene L. Andrulis University of Toronto
Timothy J. Whelan
Timothy J. Whelan McMaster University
Karen A. Gelmon
Karen A. Gelmon University of British Columbia
Patricia A. Ganz
Patricia A. Ganz University of California, Los Angeles
Dawn L. Hershman
Dawn L. Hershman Columbia University
John R. McLaughlin
John R. McLaughlin University of Toronto
Ingrid A. Mayer
Ingrid A. Mayer Vanderbilt University Medical Center
Esther M. John
Esther M. John Stanford University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re interested in healthcare but not sure about medical school, there are several alternative online degrees and career pathways to consider. These programs offer flexibility, affordability, and solid job prospects in rapidly growing sectors.

A popular option is earning an online bachelor's in health information management. This degree prepares students for careers managing patient data and ensuring healthcare compliance.

For those interested in the administrative side of healthcare, a low cost medical coding and billing online program can lead to entry-level roles and quick employment, with minimal time spent in school.

If nursing is your passion, there are several most affordable nurse practitioner programs and affordable nursing programs online. These pathways provide training for both new students and those advancing in their nursing careers.

Each of these online options offers a unique approach to building a rewarding future in healthcare, no matter your background or goals.

Best Scientists Citing Pamela J. Goodwin

Trending Scientists